1 Nuclear Medicine Diagnostic (SPECT and PET) Market Overview 1.1 Nuclear Medicine Diagnostic (SPECT and PET) Product Overview 1.2 Nuclear Medicine Diagnostic (SPECT and PET) Market Segment by Type 1.2.1 SPECT 1.2.2 PET 1.3 Global Nuclear Medicine Diagnostic (SPECT and PET) Market Size by Type 1.3.1 Global Nuclear Medicine Diagnostic (SPECT and PET) Market Size Overview by Type (2016-2027) 1.3.2 Global Nuclear Medicine Diagnostic (SPECT and PET) Historic Market Size Review by Type (2016-2021) 1.3.2.1 Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Breakdown in Volume by Type (2016-2021) 1.3.2.2 Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Breakdown in Value by Type (2016-2021) 1.3.2.3 Global Nuclear Medicine Diagnostic (SPECT and PET) Average Selling Price (ASP) by Type (2016-2021) 1.3.3 Global Nuclear Medicine Diagnostic (SPECT and PET) Forecasted Market Size by Type (2022-2027) 1.3.3.1 Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Breakdown in Volume by Type (2022-2027) 1.3.3.2 Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Breakdown in Value by Type (2022-2027) 1.3.3.3 Global Nuclear Medicine Diagnostic (SPECT and PET) Average Selling Price (ASP) by Type (2022-2027) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Nuclear Medicine Diagnostic (SPECT and PET) Sales Breakdown by Type (2016-2021) 1.4.2 Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales Breakdown by Type (2016-2021) 1.4.3 Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales Breakdown by Type (2016-2021) 1.4.4 Latin America Nuclear Medicine Diagnostic (SPECT and PET) Sales Breakdown by Type (2016-2021) 1.4.5 Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales Breakdown by Type (2016-2021) 2 Global Nuclear Medicine Diagnostic (SPECT and PET) Market Competition by Company 2.1 Global Top Players by Nuclear Medicine Diagnostic (SPECT and PET) Sales (2016-2021) 2.2 Global Top Players by Nuclear Medicine Diagnostic (SPECT and PET) Revenue (2016-2021) 2.3 Global Top Players Nuclear Medicine Diagnostic (SPECT and PET) Price (2016-2021) 2.4 Global Top Manufacturers Nuclear Medicine Diagnostic (SPECT and PET) Manufacturing Base Distribution, Sales Area, Product Type 2.5 Nuclear Medicine Diagnostic (SPECT and PET) Market Competitive Situation and Trends 2.5.1 Nuclear Medicine Diagnostic (SPECT and PET) Market Concentration Rate (2016-2021) 2.5.2 Global 5 and 10 Largest Manufacturers by Nuclear Medicine Diagnostic (SPECT and PET) Sales and Revenue in 2020 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nuclear Medicine Diagnostic (SPECT and PET) as of 2020) 2.7 Date of Key Manufacturers Enter into Nuclear Medicine Diagnostic (SPECT and PET) Market 2.8 Key Manufacturers Nuclear Medicine Diagnostic (SPECT and PET) Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Nuclear Medicine Diagnostic (SPECT and PET) Status and Outlook by Region 3.1 Global Nuclear Medicine Diagnostic (SPECT and PET) Market Size and CAGR by Region: 2016 VS 2021 VS 2026 3.2 Global Nuclear Medicine Diagnostic (SPECT and PET) Historic Market Size by Region 3.2.1 Global Nuclear Medicine Diagnostic (SPECT and PET) Sales in Volume by Region (2016-2021) 3.2.2 Global Nuclear Medicine Diagnostic (SPECT and PET) Sales in Value by Region (2016-2021) 3.2.3 Global Nuclear Medicine Diagnostic (SPECT and PET) Sales (Volume & Value) Price and Gross Margin (2016-2021) 3.3 Global Nuclear Medicine Diagnostic (SPECT and PET) Forecasted Market Size by Region 3.3.1 Global Nuclear Medicine Diagnostic (SPECT and PET) Sales in Volume by Region (2022-2027) 3.3.2 Global Nuclear Medicine Diagnostic (SPECT and PET) Sales in Value by Region (2022-2027) 3.3.3 Global Nuclear Medicine Diagnostic (SPECT and PET) Sales (Volume & Value), Price and Gross Margin (2022-2027) 4 Global Nuclear Medicine Diagnostic (SPECT and PET) by Application 4.1 Nuclear Medicine Diagnostic (SPECT and PET) Market Segment by Application 4.1.1 Oncology 4.1.2 Cardiology 4.1.3 Neurology 4.1.4 Others 4.2 Global Nuclear Medicine Diagnostic (SPECT and PET) Market Size by Application 4.2.1 Global Nuclear Medicine Diagnostic (SPECT and PET) Market Size Overview by Application (2016-2027) 4.2.2 Global Nuclear Medicine Diagnostic (SPECT and PET) Historic Market Size Review by Application (2016-2021) 4.2.2.1 Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Breakdown in Volume, by Application (2016-2021) 4.2.2.2 Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Breakdown in Value, by Application (2016-2021) 4.2.2.3 Global Nuclear Medicine Diagnostic (SPECT and PET) Average Selling Price (ASP) by Application (2016-2021) 4.2.3 Global Nuclear Medicine Diagnostic (SPECT and PET) Forecasted Market Size by Application (2022-2027) 4.2.3.1 Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Breakdown in Volume, by Application (2022-2027) 4.2.3.2 Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Breakdown in Value, by Application (2022-2027) 4.2.3.3 Global Nuclear Medicine Diagnostic (SPECT and PET) Average Selling Price (ASP) by Application (2022-2027) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Nuclear Medicine Diagnostic (SPECT and PET) Sales Breakdown by Application (2016-2021) 4.3.2 Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales Breakdown by Application (2016-2021) 4.3.3 Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales Breakdown by Application (2016-2021) 4.3.4 Latin America Nuclear Medicine Diagnostic (SPECT and PET) Sales Breakdown by Application (2016-2021) 4.3.5 Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales Breakdown by Application (2016-2021) 5 North America Nuclear Medicine Diagnostic (SPECT and PET) by Country 5.1 North America Nuclear Medicine Diagnostic (SPECT and PET) Historic Market Size by Country 5.1.1 North America Nuclear Medicine Diagnostic (SPECT and PET) Sales in Volume by Country (2016-2021) 5.1.2 North America Nuclear Medicine Diagnostic (SPECT and PET) Sales in Value by Country (2016-2021) 5.2 North America Nuclear Medicine Diagnostic (SPECT and PET) Forecasted Market Size by Country 5.2.1 North America Nuclear Medicine Diagnostic (SPECT and PET) Sales in Volume by Country (2022-2027) 5.2.2 North America Nuclear Medicine Diagnostic (SPECT and PET) Sales in Value by Country (2022-2027) 6 Europe Nuclear Medicine Diagnostic (SPECT and PET) by Country 6.1 Europe Nuclear Medicine Diagnostic (SPECT and PET) Historic Market Size by Country 6.1.1 Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales in Volume by Country (2016-2021) 6.1.2 Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales in Value by Country (2016-2021) 6.2 Europe Nuclear Medicine Diagnostic (SPECT and PET) Forecasted Market Size by Country 6.2.1 Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales in Volume by Country (2022-2027) 6.2.2 Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales in Value by Country (2022-2027) 7 Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) by Region 7.1 Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) Historic Market Size by Region 7.1.1 Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales in Volume by Region (2016-2021) 7.1.2 Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales in Value by Region (2016-2021) 7.2 Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) Forecasted Market Size by Region 7.2.1 Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales in Volume by Region (2022-2027) 7.2.2 Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales in Value by Region (2022-2027) 8 Latin America Nuclear Medicine Diagnostic (SPECT and PET) by Country 8.1 Latin America Nuclear Medicine Diagnostic (SPECT and PET) Historic Market Size by Country 8.1.1 Latin America Nuclear Medicine Diagnostic (SPECT and PET) Sales in Volume by Country (2016-2021) 8.1.2 Latin America Nuclear Medicine Diagnostic (SPECT and PET) Sales in Value by Country (2016-2021) 8.2 Latin America Nuclear Medicine Diagnostic (SPECT and PET) Forecasted Market Size by Country 8.2.1 Latin America Nuclear Medicine Diagnostic (SPECT and PET) Sales in Volume by Country (2022-2027) 8.2.2 Latin America Nuclear Medicine Diagnostic (SPECT and PET) Sales in Value by Country (2022-2027) 9 Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) by Country 9.1 Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Historic Market Size by Country 9.1.1 Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales in Volume by Country (2016-2021) 9.1.2 Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales in Value by Country (2016-2021) 9.2 Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Forecasted Market Size by Country 9.2.1 Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales in Volume by Country (2022-2027) 9.2.2 Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales in Value by Country (2022-2027) 10 Company Profiles and Key Figures in Nuclear Medicine Diagnostic (SPECT and PET) Business 10.1 GE Healthcare 10.1.1 GE Healthcare Corporation Information 10.1.2 GE Healthcare Introduction and Business Overview 10.1.3 GE Healthcare Nuclear Medicine Diagnostic (SPECT and PET) Sales, Revenue and Gross Margin (2016-2021) 10.1.4 GE Healthcare Nuclear Medicine Diagnostic (SPECT and PET) Products Offered 10.1.5 GE Healthcare Recent Development 10.2 Siemens Healthineers 10.2.1 Siemens Healthineers Corporation Information 10.2.2 Siemens Healthineers Introduction and Business Overview 10.2.3 Siemens Healthineers Nuclear Medicine Diagnostic (SPECT and PET) Sales, Revenue and Gross Margin (2016-2021) 10.2.4 GE Healthcare Nuclear Medicine Diagnostic (SPECT and PET) Products Offered 10.2.5 Siemens Healthineers Recent Development 10.3 Philips Healthcare 10.3.1 Philips Healthcare Corporation Information 10.3.2 Philips Healthcare Introduction and Business Overview 10.3.3 Philips Healthcare Nuclear Medicine Diagnostic (SPECT and PET) Sales, Revenue and Gross Margin (2016-2021) 10.3.4 Philips Healthcare Nuclear Medicine Diagnostic (SPECT and PET) Products Offered 10.3.5 Philips Healthcare Recent Development 10.4 Mediso 10.4.1 Mediso Corporation Information 10.4.2 Mediso Introduction and Business Overview 10.4.3 Mediso Nuclear Medicine Diagnostic (SPECT and PET) Sales, Revenue and Gross Margin (2016-2021) 10.4.4 Mediso Nuclear Medicine Diagnostic (SPECT and PET) Products Offered 10.4.5 Mediso Recent Development 10.5 Spectrum Dynamics 10.5.1 Spectrum Dynamics Corporation Information 10.5.2 Spectrum Dynamics Introduction and Business Overview 10.5.3 Spectrum Dynamics Nuclear Medicine Diagnostic (SPECT and PET) Sales, Revenue and Gross Margin (2016-2021) 10.5.4 Spectrum Dynamics Nuclear Medicine Diagnostic (SPECT and PET) Products Offered 10.5.5 Spectrum Dynamics Recent Development 10.6 Bruker 10.6.1 Bruker Corporation Information 10.6.2 Bruker Introduction and Business Overview 10.6.3 Bruker Nuclear Medicine Diagnostic (SPECT and PET) Sales, Revenue and Gross Margin (2016-2021) 10.6.4 Bruker Nuclear Medicine Diagnostic (SPECT and PET) Products Offered 10.6.5 Bruker Recent Development 10.7 SurgicEye 10.7.1 SurgicEye Corporation Information 10.7.2 SurgicEye Introduction and Business Overview 10.7.3 SurgicEye Nuclear Medicine Diagnostic (SPECT and PET) Sales, Revenue and Gross Margin (2016-2021) 10.7.4 SurgicEye Nuclear Medicine Diagnostic (SPECT and PET) Products Offered 10.7.5 SurgicEye Recent Development 10.8 MIE 10.8.1 MIE Corporation Information 10.8.2 MIE Introduction and Business Overview 10.8.3 MIE Nuclear Medicine Diagnostic (SPECT and PET) Sales, Revenue and Gross Margin (2016-2021) 10.8.4 MIE Nuclear Medicine Diagnostic (SPECT and PET) Products Offered 10.8.5 MIE Recent Development 10.9 MILabs 10.9.1 MILabs Corporation Information 10.9.2 MILabs Introduction and Business Overview 10.9.3 MILabs Nuclear Medicine Diagnostic (SPECT and PET) Sales, Revenue and Gross Margin (2016-2021) 10.9.4 MILabs Nuclear Medicine Diagnostic (SPECT and PET) Products Offered 10.9.5 MILabs Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Nuclear Medicine Diagnostic (SPECT and PET) Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Nuclear Medicine Diagnostic (SPECT and PET) Industrial Chain Analysis 11.4 Nuclear Medicine Diagnostic (SPECT and PET) Market Dynamics 11.4.1 Industry Trends 11.4.2 Market Drivers 11.4.3 Market Challenges 11.4.4 Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Nuclear Medicine Diagnostic (SPECT and PET) Distributors 12.3 Nuclear Medicine Diagnostic (SPECT and PET) Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Major Company of SPECT Table 2. Major Company of PET Table 3. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales by Type 2016 VS 2021 VS 2027 (US$ Million) Table 4. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales by Type (2016-2021) & (K Units) Table 5. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Volume by Type (2016-2021) Table 6. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales by Type (2016-2021) & (US& Million) Table 7. Global Nuclear Medicine Diagnostic (SPECT and PET) Market Share in Value by Type (2016-2021) Table 8. Global Nuclear Medicine Diagnostic (SPECT and PET) Price by Type (2016-2021) & (US$/Unit) Table 9. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales by Type (2022-2027) & (K Units) Table 10. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Volume by Type (2022-2027) Table 11. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales by Type (2022-2027) & (US$ Million) Table 12. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Value by Type (2022-2027) Table 13. Global Nuclear Medicine Diagnostic (SPECT and PET) Price by Type (2022-2027) & (US$/Unit) Table 14. North America Nuclear Medicine Diagnostic (SPECT and PET) Sales by Type (2016-2021) & (K Units) Table 15. North America Nuclear Medicine Diagnostic (SPECT and PET) Sales by Type (2016-2021) & (US$ Million) Table 16. Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales (K Units) by Type (2016-2021) Table 17. Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales by Type (2016-2021) & (US$ Million) Table 18. Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales (K Units) by Type (2016-2021) Table 19. Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales by Type (2016-2021) & (US$ Million) Table 20. Latin America Nuclear Medicine Diagnostic (SPECT and PET) Sales (K Units) by Type (2016-2021) Table 21. Latin America Nuclear Medicine Diagnostic (SPECT and PET) Sales by Type (2016-2021) & (US$ Million) Table 22. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales (K Units) by Type (2016-2021) Table 23. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales by Type (2016-2021) & (US$ Million) Table 24. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales by Company (2016-2021) & (K Units) Table 25. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Share by Company (2016-2021) Table 26. Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Company (2016-2021) & (US$ Million) Table 27. Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue Share by Company (2016-2021) Table 28. Global Market Nuclear Medicine Diagnostic (SPECT and PET) Price by Company (2016-2021) & (US$/Unit) Table 29. Global Nuclear Medicine Diagnostic (SPECT and PET) Top Manufacturers Manufacturing Base Distribution and Sales Area Table 30. Global Nuclear Medicine Diagnostic (SPECT and PET) Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nuclear Medicine Diagnostic (SPECT and PET) as of 2020 Table 32. Date of Key Manufacturers Enter into Nuclear Medicine Diagnostic (SPECT and PET) Market Table 33. Key Manufacturers Nuclear Medicine Diagnostic (SPECT and PET) Product Type Table 34. Mergers & Acquisitions, Expansion Plans Table 35. Global Nuclear Medicine Diagnostic (SPECT and PET) Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027 Table 36. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales by Region (2016-2021) & (K Units) Table 37. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Volume by Region (2016-2021) Table 38. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales by Region (2016-2021) & (US$ Million) Table 39. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Value by Region (2016-2021) Table 40. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 41. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales by Region (2022-2027) & (K Units) Table 42. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Volume by Region (2022-2027) Table 43. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales by Region (2022-2027) & (US$ Million) Table 44. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Value by Region (2022-2027) Table 45. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2022-2027) Table 46. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales by Application: 2016 VS 2021 VS 2027 (US$ Million) Table 47. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales by Application (2016-2021) & (K Units) Table 48. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Volume by Application (2016-2021) Table 49. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales by Application (2016-2021) & (US$ Million) Table 50. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Value by Application (2016-2021) Table 51. Global Nuclear Medicine Diagnostic (SPECT and PET) Price by Application (2016-2021) & (US$/Unit) Table 52. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales by Application (2022-2027) & (K Units) Table 53. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Volume by Application (2022-2027) Table 54. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales by Application (2022-2027) & (US$ Million) Table 55. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Value by Application (2022-2027) Table 56. Global Nuclear Medicine Diagnostic (SPECT and PET) Price by Application (2022-2027) & (US$/Unit) Table 57. North America Nuclear Medicine Diagnostic (SPECT and PET) Sales by Application (2016-2021) (K Units) Table 58. North America Nuclear Medicine Diagnostic (SPECT and PET) Sales by Application (2016-2021) & (US$ Million) Table 59. North America Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Value by Application in 2020 Table 60. Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales by Application (2016-2021) (K Units) Table 61. Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales by Application (2016-2021) & (US$ Million) Table 62. Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Value by Application in 2020 Table 63. Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales by Application (2016-2021) (K Units) Table 64. Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales by Application (2016-2021) & (US$ Million) Table 65. Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Value by Application in 2020 Table 66. Latin America Nuclear Medicine Diagnostic (SPECT and PET) Sales by Application (2016-2021) (K Units) Table 67. Latin America Nuclear Medicine Diagnostic (SPECT and PET) Sales by Application (2016-2021) & (US$ Million) Table 68. Latin America Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Value by Application in 2020 Table 69. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales by Application (2016-2021) (K Units) Table 70. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales by Application (2016-2021) & (US$ Million) Table 71. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Value by Application in 2020 Table 72. North America Nuclear Medicine Diagnostic (SPECT and PET) Sales by Country (2016-2021) & (K Units) Table 73. North America Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Volume by Country (2016-2021) Table 74. North America Nuclear Medicine Diagnostic (SPECT and PET) Sales by Country (2016-2021) & (US$ Million) Table 75. North America Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Value by Country (2016-2021) Table 76. North America Nuclear Medicine Diagnostic (SPECT and PET) Sales by Country (2022-2027) & (K Units) Table 77. North America Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Volume by Country (2022-2027) Table 78. North America Nuclear Medicine Diagnostic (SPECT and PET) Sales by Country (2022-2027) & (US$ Million) Table 79. North America Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Value by Country (2022-2027) Table 80. Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales by Country (2016-2021) & (K Units) Table 81. Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Volume by Country (2016-2021) Table 82. Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales by Country (2016-2021) & (US$ Million) Table 83. Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Value by Country (2016-2021) Table 84. Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales by Country (2022-2027) & (K Units) Table 85. Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Volume by Country (2022-2027) Table 86. Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales by Country (2022-2027) & (US$ Million) Table 87. Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Value by Country (2022-2027) Table 88. Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales by Region (2016-2021) & (K Units) Table 89. Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Volume by Region (2016-2021) Table 90. Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales by Region (2016-2021) & (US$ Million) Table 91. Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Value by Region (2016-2021) Table 92. Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales by Region (2022-2027) & (K Units) Table 93. Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Volume by Region (2022-2027) Table 94. Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales by Region (2022-2027) & (US$ Million) Table 95. Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Value by Region (2022-2027) Table 96. Latin America Nuclear Medicine Diagnostic (SPECT and PET) Sales by Country (2016-2021) & (K Units) Table 97. Latin America Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Volume by Country (2016-2021) Table 98. Latin America Nuclear Medicine Diagnostic (SPECT and PET) Sales by Country (2016-2021) & (US$ Million) Table 99. Latin America Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Value by Country (2016-2021) Table 100. Latin America Nuclear Medicine Diagnostic (SPECT and PET) Sales by Country (2022-2027) & (K Units) Table 101. Latin America Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Volume by Country (2022-2027) Table 102. Latin America Nuclear Medicine Diagnostic (SPECT and PET) Sales by Country (2022-2027) & (US$ Million) Table 103. Latin America Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Value by Country (2022-2027) Table 104. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales by Country (2016-2021) & (K Units) Table 105. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Volume by Country (2016-2021) Table 106. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales by Country (2016-2021) & (US$ Million) Table 107. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Value by Country (2016-2021) Table 108. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales by Country (2022-2027) & (K Units) Table 109. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Volume by Country (2022-2027) Table 110. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales by Country (2022-2027) & (US$ Million) Table 111. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Value by Country (2022-2027) Table 112. GE Healthcare Corporation Information Table 113. GE Healthcare Introduction and Business Overview Table 114. GE Healthcare Nuclear Medicine Diagnostic (SPECT and PET) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 115. GE Healthcare Nuclear Medicine Diagnostic (SPECT and PET) Product Table 116. GE Healthcare Recent Development Table 117. Siemens Healthineers Corporation Information Table 118. Siemens Healthineers Introduction and Business Overview Table 119. Siemens Healthineers Nuclear Medicine Diagnostic (SPECT and PET) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 120. Siemens Healthineers Nuclear Medicine Diagnostic (SPECT and PET) Product Table 121. Siemens Healthineers Recent Development Table 122. Philips Healthcare Corporation Information Table 123. Philips Healthcare Introduction and Business Overview Table 124. Philips Healthcare Nuclear Medicine Diagnostic (SPECT and PET) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 125. Philips Healthcare Nuclear Medicine Diagnostic (SPECT and PET) Product Table 126. Philips Healthcare Recent Development Table 127. Mediso Corporation Information Table 128. Mediso Introduction and Business Overview Table 129. Mediso Nuclear Medicine Diagnostic (SPECT and PET) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 130. Mediso Nuclear Medicine Diagnostic (SPECT and PET) Product Table 131. Mediso Recent Development Table 132. Spectrum Dynamics Corporation Information Table 133. Spectrum Dynamics Introduction and Business Overview Table 134. Spectrum Dynamics Nuclear Medicine Diagnostic (SPECT and PET) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 135. Spectrum Dynamics Nuclear Medicine Diagnostic (SPECT and PET) Product Table 136. Spectrum Dynamics Recent Development Table 137. Bruker Corporation Information Table 138. Bruker Introduction and Business Overview Table 139. Bruker Nuclear Medicine Diagnostic (SPECT and PET) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 140. Bruker Nuclear Medicine Diagnostic (SPECT and PET) Product Table 141. Bruker Recent Development Table 142. SurgicEye Corporation Information Table 143. SurgicEye Introduction and Business Overview Table 144. SurgicEye Nuclear Medicine Diagnostic (SPECT and PET) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 145. SurgicEye Nuclear Medicine Diagnostic (SPECT and PET) Product Table 146. SurgicEye Recent Development Table 147. MIE Corporation Information Table 148. MIE Introduction and Business Overview Table 149. MIE Nuclear Medicine Diagnostic (SPECT and PET) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 150. MIE Nuclear Medicine Diagnostic (SPECT and PET) Product Table 151. MIE Recent Development Table 152. MILabs Corporation Information Table 153. MILabs Introduction and Business Overview Table 154. MILabs Nuclear Medicine Diagnostic (SPECT and PET) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 155. MILabs Nuclear Medicine Diagnostic (SPECT and PET) Product Table 156. MILabs Recent Development Table 157. Key Raw Materials Lists Table 158. Raw Materials Key Suppliers Lists Table 159. Nuclear Medicine Diagnostic (SPECT and PET) Market Trends Table 160. Nuclear Medicine Diagnostic (SPECT and PET) Market Drivers Table 161. Nuclear Medicine Diagnostic (SPECT and PET) Market Challenges Table 162. Nuclear Medicine Diagnostic (SPECT and PET) Market Restraints Table 163. Nuclear Medicine Diagnostic (SPECT and PET) Distributors List Table 164. Nuclear Medicine Diagnostic (SPECT and PET) Downstream Customers Table 165. Research Programs/Design for This Report Table 166. Key Data Information from Secondary Sources Table 167. Key Data Information from Primary Sources List of Figures Figure 1. Nuclear Medicine Diagnostic (SPECT and PET) Product Picture Figure 2. Global Nuclear Medicine Diagnostic (SPECT and PET) Market Size, 2016 VS 2021 VS 2027 (US$ Million) Figure 3. Global Nuclear Medicine Diagnostic (SPECT and PET) Market Size Status and Outlook (2016-2027) & (US$ Million) Figure 4. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Status and Outlook (2016-2027) & (K Units) Figure 5. Product Picture of SPECT Figure 6. Global SPECT Sales YoY Growth (2016-2021) & (K Units) Figure 7. Product Picture of PET Figure 8. Global PET Sales YoY Growth (2016-2021) & (K Units) Figure 9. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales by Type (2016-2027) & (US$ Million) Figure 10. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Volume by Type (2016-2021) Figure 11. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Value by Type (2016-2021) Figure 12. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Volume by Type (2022-2027) Figure 13. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Value by Type (2022-2027) Figure 14. North America Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Volume by Type in 2020 Figure 15. North America Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Value by Type in 2020 Figure 16. Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Volume by Type in 2020 Figure 17. Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Value by Type in 2020 Figure 18. Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Volume by Type in 2020 Figure 19. Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Value by Type in 2020 Figure 20. Latin America Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Volume by Type in 2020 Figure 21. Latin America Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Value by Type in 2020 Figure 22. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Volume by Type in 2020 Figure 23. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Value by Type in 2020 Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Nuclear Medicine Diagnostic (SPECT and PET) Sales in 2020 Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Nuclear Medicine Diagnostic (SPECT and PET) Revenue in 2020 Figure 26. Nuclear Medicine Diagnostic (SPECT and PET) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 27. Product Picture of Oncology Figure 28. Global Oncology Sales YoY Growth (2016-2027) & (K Units) Figure 29. Product Picture of Cardiology Figure 30. Global Cardiology Sales YoY Growth (2016-2027) & (K Units) Figure 31. Product Picture of Neurology Figure 32. Global Neurology Sales YoY Growth (2016-2027) & (K Units) Figure 33. Product Picture of Others Figure 34. Global Others Sales YoY Growth (2016-2027) & (K Units) Figure 35. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales by Application (2016-2027) & (US$ Million) Figure 36. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Volume by Application (2016-2021) Figure 37. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Value by Application (2016-2021) Figure 38. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Volume by Application (2022-2027) Figure 39. North America Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Volume by Application in 2020 Figure 40. Latin America Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Value by Application in 2020 Figure 41. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share in Value by Application in 2020 Figure 42. Key Raw Materials Price Figure 43. Nuclear Medicine Diagnostic (SPECT and PET) Manufacturing Cost Structure Figure 44. Nuclear Medicine Diagnostic (SPECT and PET) Industrial Chain Analysis Figure 45. Channels of Distribution Figure 46. Distributors Profiles Figure 47. Bottom-up and Top-down Approaches for This Report Figure 48. Data Triangulation Figure 49. Key Executives Interviewed

GE Healthcare Siemens Healthineers Philips Healthcare Mediso Spectrum Dynamics Bruker SurgicEye MIE MILabs